Hepatitis is the 10th leading cause of death worldwide and became a serious global health problem. About 2 billion people are suffering from Hepatitis worldwide.
Beacon Pharmaceuticals Limited is one the icon in providing treatment for global hepatitis sufferers. After the success in cancer treatment, Beacon is now producing and supplying latest Hepatitis drugs. Beacon has introduced all the latest Hepatitis drugs. Recently the company has introduced global 1st generic of Daclatasvir, the research molecule of Bristol Myer Squibb.
Beacon has rich pipeline of drugs for Hepatitis treatment and already introduced 7 latest drugs. Beacon is providing all these products in 54 countries under the Hepatitis support program.